Literature DB >> 2649460

Keynote address: hypoxic cell sensitizers: clinical developments.

S Dische1.   

Abstract

"Tumours having small islands of cells should be radiosensitive, and those having large masses, radioresistant. This was found to be the case and there is a ready explanation for this: the outside cells are close to blood vessels and will thus be well supplied with oxygen, whilst the inside cells are not well placed in this respect. Now it is known that cells well supplied with oxygen are radiosensitive, compared to the same cells deprived of oxygen; it is therefore likely that for this reason, variation in blood supply, that the outside cells are more easily destroyed than those within."

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649460     DOI: 10.1016/0360-3016(89)90915-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

Review 1.  Cellular approaches to bioreductive drug mechanisms.

Authors:  A M Rauth; R S Marshall; B L Kuehl
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

2.  Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.

Authors:  D J Chaplin; M J Trotter; K A Skov; M R Horsman
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

3.  The radiosensitizing effect of doranidazole on human colorectal cancer cells exposed to high doses of irradiation.

Authors:  Li Zhang; Aimin Gong; Jun Ji; Yuanyuan Wu; Xiaoyu Zhu; Suqing Lv; Hongzhu Lv; Xizhuo Sun
Journal:  BMC Cancer       Date:  2007-10-06       Impact factor: 4.430

4.  Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.

Authors:  D J Chaplin; M R Horsman; D S Aoki
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.